Nguyen
10-21-2022, 09:22 AM
Switch to Fulvestrant and Palbociclib vs No Switch in Advanced Breast Cancer With Rising ESR1 Mutations During Aromatase Inhibitor and Palbociclib Therapy
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00555-1/fulltext
Note the "take home message" section and DO's comment. But I think one of the key point is the use of liquid biopsy to change regimen.
https://www.practiceupdate.com/c/142695/67/13/?elsca1=emc_enews_weekinreview&elsca2=email&elsca3=practiceupdate_metastaticbreastcancer&elsca4=metastaticbreastcancer&elsca5=newsletter&rid=NjIyODUwOTM0NDgS1&lid=20849614
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00555-1/fulltext
Note the "take home message" section and DO's comment. But I think one of the key point is the use of liquid biopsy to change regimen.
https://www.practiceupdate.com/c/142695/67/13/?elsca1=emc_enews_weekinreview&elsca2=email&elsca3=practiceupdate_metastaticbreastcancer&elsca4=metastaticbreastcancer&elsca5=newsletter&rid=NjIyODUwOTM0NDgS1&lid=20849614